PINK

Simplify Health Care ETF · PSE

Category Health Care
Expense Ratio 0.5%
Listing Date Oct 08, 2021
Volume 32,386.0
Market Cap (AUM) $147.15M

Performance

-1.57%

-0.96%

-9.57%

-0.57%

+10.12%

YTD

+15.42%

Top Holdings

Name
Symbol
%Assets
Sarepta Therapeutics, Inc.SRPT9.71%
Eli Lilly and CompanyLLY7.61%
Insmed IncorporatedINSM6.91%
UnitedHealth Group IncorporatedUNH6.51%
Merck & Co., Inc.MRK5.13%
Regeneron Pharmaceuticals, Inc.REGN5.00%
Intuitive Surgical, Inc.ISRG4.99%
PureCycle Technologies IncPCT4.76%
Boston Scientific CorporationBSX4.62%
Novo Nordisk A/S Sponsored ADR Class BNVO4.19%

Advanced Technical Analysis

Technical Analysis of PINK 2024-12-20

The stock's Moving Average Score of 10 indicates a strong bearish sentiment, while the Oscillators Score of 56 suggests a neutral stance. Overall, the Technical Score of 33 reinforces the bearish outlook, indicating that the stock may face downward pressure in the near term.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Recent News & Updates

2024-02-28 13:30
Be wary of 'concentration risks' in tech ETFs: Strategist(Yahoo Finance Video)
2023-12-15 19:00
Simplify Provides Estimated Capital Gain Distribution Information for 2023(Business Wire)
2023-10-30 15:00
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights(Yahoo Finance)
2022-10-11 21:05
Simplify Presents Six-figure Check to Susan G. KomenÂ®, Marking One Year Since the Launch of the Simplify Health Care ETF (PINK)(Yahoo Finance)
2022-05-16 20:56
Simplify Announces Launch of the Simplify Macro Strategy ETF (FIG) Led by Hedge Fund Veteran Michael Green(Yahoo Finance)
2021-12-27 19:57
Simplify Asset Managements Innovative Lineup of Exchange-traded Funds Passes the $1 Billion Asset Threshold(Yahoo Finance)

Page 1 of 1

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.